Paul R Rhomberg Selected Research

Soft Tissue Infections

9/2016

In vitro spectrum of pexiganan activity; bactericidal action and resistance selection tested against pathogens with elevated MIC values to topical agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul R Rhomberg Research Topics

Disease

27	Infections 11/2022 - 02/2002
5	Invasive Fungal Infections 01/2022 - 06/2016
4	Pneumonia (Pneumonitis) 06/2021 - 07/2014
3	Mycoses (Diseases, Fungus) 11/2021 - 10/2016
3	Ventilator-Associated Pneumonia 01/2018 - 07/2014
3	Catheter-Related Infections 05/2008 - 03/2008
2	Candidiasis (Moniliasis) 01/2020 - 01/2017
2	Bacterial Pneumonia 01/2017 - 06/2010
1	Invasive Candidiasis 01/2022
1	Candidemia 01/2022
1	Sepsis (Septicemia) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Soft Tissue Infections 09/2016
1	Breakthrough Infections 06/2016
1	Ulcer 03/2015
1	Diabetic Foot 03/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2014
1	Neoplasms (Cancer) 07/2010
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2010
1	Meningitis 12/2009
1	Cross Infection (Nosocomial Infection) 09/2003

Drug/Important Bio-Agent (IBA)

8	EchinocandinsIBA 11/2022 - 03/2008
8	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 09/2003
6	RezafunginIBA 11/2022 - 10/2016
5	Anti-Infective Agents (Microbicides)IBA 03/2015 - 12/2002
4	Peptides (Polypeptides)IBA 03/2015 - 03/2008
3	Fosfomycin FDA Link 02/2019 - 07/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 07/2014 - 07/2010
3	Meropenem (Merrem)FDA LinkGeneric 12/2009 - 08/2004
3	OmigananIBA 05/2008 - 03/2008
2	tedizolidIBA 06/2021 - 02/2015
2	AzolesIBA 06/2021 - 03/2008
2	omadacyclineIBA 01/2017 - 01/2017
2	Amikacin (A.M.K)FDA LinkGeneric 07/2014 - 07/2014
2	beta-LactamsIBA 12/2009 - 12/2002
2	Serine (L-Serine)FDA Link 09/2008 - 02/2007
2	beta-Lactamases (beta-Lactamase)IBA 09/2008 - 09/2003
2	omiganan pentahydrochlorideIBA 05/2008 - 03/2008
1	Ceftibuten (Cedax)FDA Link 01/2022
1	Antifungal AgentsIBA 11/2021
1	iclaprim (AR 100)IBA 01/2021
1	SPR741IBA 04/2020
1	Fluconazole (Zonal)FDA LinkGeneric 01/2020
1	tebipenemIBA 01/2019
1	murepavadinIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	ibrexafungerpIBA 01/2017
1	Cefepime (Maxipime)FDA LinkGeneric 01/2017
1	cefepime-zidebactamIBA 01/2017
1	zidebactamIBA 01/2017
1	Fusidic Acid (Fucithalmic)IBA 09/2016
1	polymyxin B drug combination bacitracin (Polysporin)FDA Link 09/2016
1	Gentamicins (Gentamicin)FDA LinkGeneric 09/2016
1	retapamulin FDA Link 09/2016
1	Neomycin FDA LinkGeneric 09/2016
1	Mupirocin (Bactroban)FDA LinkGeneric 09/2016
1	carbapenemaseIBA 01/2016
1	meropenem and vaborbactamIBA 01/2016
1	CoagulaseIBA 05/2015
1	CationsIBA 03/2015
1	pexigananIBA 03/2015
1	Oxazolidinones (2 Oxazolidone)IBA 02/2015
1	arbekacinIBA 01/2015
1	telavancin FDA Link 12/2014
1	Biological ProductsIBA 12/2014
1	Polymyxins (Polymyxin)IBA 03/2013
1	QuinolonesIBA 07/2010
1	solithromycinIBA 06/2010
1	Methicillin (Metin)FDA Link 12/2009
1	PleuromutilinsIBA 02/2002
1	tiamulinIBA 02/2002
1	Tigecycline (Tygacil)FDA Link 02/2002
1	Tetracycline (Achromycin)FDA LinkGeneric 02/2002
1	Minocycline (Cyclops)FDA LinkGeneric 02/2002
1	FluoroquinolonesIBA 02/2002
1	Doxycycline (Periostat)FDA LinkGeneric 02/2002

Therapy/Procedure

6	Therapeutics 01/2017 - 02/2002
2	Nebulizers and Vaporizers (Inhaler) 07/2014 - 07/2014
1	Lasers (Laser) 03/2016
1	Artificial Respiration (Mechanical Ventilation) 07/2014